Skip to main content
Book Chapter

High-LET-emitting radionuclides for cancer therapy

Springer Netherlands, (2008), 175-180
DOI: 10.1007/978-1-4020-8696-0_9
1Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

During the last 15 years, alpha-particle emitting radionuclides have been investigated as a possible new class of radionuclides for targeted therapy. Alpha-particles can deposit DNA damaging energy 100 to 1,000 times greater than beta-particles. In this chapter, the background and clinical experiences of targeted alpha-particle radioimmunotherapy use are discussed. © 2008 Springer Science+Business Media B.V.

Cite

CITATION STYLE

APA

Sgouros, G. (2008). High-LET-emitting radionuclides for cancer therapy. In Targeted Radionuclide Tumor Therapy: Biological Aspects (pp. 175–180). Springer Netherlands. https://doi.org/10.1007/978-1-4020-8696-0_9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free